🇺🇸

Corporate Governance

US SEC Filing Intelligence · 463 digests

New to these filings? Learn what a DEF 14A proxy statement is

· daily

US Executive Compensation Proxy SEC Filings — October 16, 2026

This stream covers 11 US SEC DEF 14A and DEFM14A filings dated October 16, 2026, centered on executive pay, governance, and shareholder proposals. The filings are dominated by governance-procedural items: director elections, say-on-pay advisory votes, auditor ratifications, and reverse stock split authorizations recur across most of the set. The most material development is Victory Capital's $7.03 billion acquisition of First Eagle, which carries purchase-price adjustment risk tied to client consents and a fallback mechanism if the share issuance proposal fails. Eagle Financial's merger with JMSB is also high-materiality, with pro forma net income of $25.7 million for the six months ended June 30, 2026 versus $13.1 million standalone for JMSB, though integration charges remain unquantified. Governance concentration is a recurring pattern: Cheetah Net and Iveda both combine the CEO and Chairman roles without a lead independent director. Several filings lack quantitative period-over-period data, so trend-based conclusions are limited, and the executive compensation disclosures that anchor this stream's focus are largely absent from the excerpts provided.

11 high priority 11 total filings
· daily

US Executive Officer Management Changes SEC — October 16, 2026

The 34 filings in this Officer and Director Change stream are dominated by executive turnover rather than quantified performance: most 8-Ks carry no financial metrics, so period-over-period comparisons are largely unavailable. The clearest market-moving item is Fox Factory's preliminary Q3 FY2026 miss and FY2026 guidance cut (net sales guidance lowered to $1.35B-$1.38B from $1.42B-$1.47B; adjusted EBITDA to $140M-$150M from $176M-$196M) coinciding with the CEO's exit and an interim CEO appointment. Several CFO transitions cluster across small and micro-cap issuers (CalciMedica, WidePoint, GBank Financial, Feel The World, Emergent BioSolutions, Union Pacific), with interim or unnamed successors in multiple cases, which raises financial-reporting continuity risk. Governance activity is heavy at small caps (Quantum Cyber, Change Agents, Odyssey Marine, Waterstone, TScan) where independent director additions and resignations reshape committee composition. Corporate-action items of note include MiniMed's completed separation from Medtronic (exchange 5.4x subscribed), Odyssey Marine's 1-for-25 reverse split ahead of a merger vote, and Silver Bow Mining's dilutive CEO performance warrant package.

34 high priority 34 total filings
· daily

US Corporate Board Director Changes SEC Filings — October 16, 2026

Across the 34 filings in this Board Room Changes stream, the dominant theme is executive and board turnover rather than financial performance: most filings are officer or director departures, appointments, or compensation disclosures with no quantitative results attached. The most material development is Fox Factory's CEO exit alongside a sharp FY2026 guidance cut (net sales to $1.35B-$1.38B from $1.42B-$1.47B; adjusted EBITDA to $140M-$150M from $176M-$196M), which pairs leadership change with deteriorating fundamentals. Capital-markets and governance-driven events are also prominent: MiniMed completed its Medtronic separation (55.0M Medtronic shares exchanged for 252.8M MiniMed shares, 5.4x subscribed), Odyssey Marine announced a 1-for-25 reverse split tied to a merger, and Silver Bow Mining proposed large new CEO performance warrant grants. Several CFO transitions cluster in the period (CalciMedica, GBank, WidePoint, Union Pacific's Hamann retirement, Emergent's Lindahl retirement, Feel The World, Farmhouse), a pattern that warrants monitoring for reporting-quality or governance signals. Quantitative period-over-period data is largely absent from these filings, so comparative conclusions are limited to the handful that disclose figures.

34 high priority 34 total filings
· daily

US Executive Compensation Proxy SEC Filings — October 15, 2026

This digest covers seven DEF 14A filings dated October 15, 2026, but the stream is framed around executive compensation, governance and shareholder proposals, and the filings themselves are dominated by meeting logistics, SPAC extension mechanics and financing terms rather than pay disclosures. No period-over-period financial comparisons, insider transactions, or quantified guidance are actually present in the filing summaries provided, so trend analysis is limited to governance and voting dynamics. The most material developments are the SPAC extension risk at ClimateRock (sponsor control of ~94% of votes, redemption-driven cash shortfall risk), the Cactus Acquisition Corp. 1 extension vote ahead of a November 2, 2026 termination date, and Boxlight's Series D preferred financing with a 20% default dividend, stated-value step-up and an unfulfilled special-meeting obligation. Several shareholder votes are close or uncertain, notably Korsana's redomestication, which previously won a majority of votes cast but failed the statutory two-thirds thresholds. Across the set, the common thread is that shareholder approval thresholds and contingent conditions, not operating performance, will determine outcomes in the near term.

7 high priority 7 total filings
· daily

US Executive Officer Management Changes SEC — October 15, 2026

The 35 filings in this stream are dominated by executive and director changes rather than financial results: most disclosures are routine board appointments, planned retirements, or CFO transitions, and very few carry quantitative period-over-period data. Across the set, CFO turnover is the most frequent theme (Verra Mobility, Sinda, Super Micro, Hyster-Yale, Actinium, Orion, Carpenter-adjacent legal transitions), with several companies replacing finance leadership within weeks of a departure, which raises execution and reporting-continuity questions. The most material developments are Bansal & Co's resignation and withdrawal of audit reports for FY2019–2025 at Ameritek Ventures, the unresolved closing condition on Hain Celestial's International divestiture, and Verra Mobility's decision to skip its Q3 earnings call amid a CFO and CEO transition. Insider-conviction signals are limited, but retention packages (MongoDB, BJ's Wholesale, Orion) and a large Super Micro CFO package suggest boards are paying up to stabilize leadership. Portfolio-level, the data show a pattern of planned succession (Hamilton Lane, ManpowerGroup, Caterpillar, Arrow, LeMaitre) that is generally low-risk, while unplanned or unexplained departures (Sinda, Super Micro, Verra) warrant closer monitoring. Because the enriched period-comparison and forward-looking fields are largely empty for these governance filings, most signals below are qualitative and should be weighted accordingly.

35 high priority 35 total filings
· daily

US Corporate Board Director Changes SEC Filings — October 15, 2026

The 35 filings in this board-room stream are overwhelmingly governance-and-leadership disclosures rather than financial events: most carry no reported financial results, period-over-period comparisons, or forward guidance, so the enriched quantitative fields are largely empty for this batch. The dominant themes are CFO turnover (Verra Mobility, Sinda, Super Micro, Hyster-Yale, Actinium, Pineapple/Pentiv, Synaptics), director departures tied to retirements or other commitments (Blackstone/Medline Baratta, Compass Minerals, Olema, Biomerica), and planned succession at senior levels (ManpowerGroup, Hamilton Lane, Carpenter, Arrow, Caterpillar, LeMaitre). The single most material development is Ameritek Ventures, where the auditor resigned and withdrew audit reports for FY2019 through FY2025 after a court ruled the custodian improperly appointed, creating a severe reliability problem for the company's financial history. Hain Celestial's pending International divestiture to AURELIUS also stalled on a missed lender-amendment closing condition with no revised timeline. Several CFO transitions occur in close proximity to scheduled reporting dates, notably Verra Mobility's Q3 release on October 30 without a conference call, which warrants attention to the quality of that disclosure.

35 high priority 35 total filings
· daily

US Executive Compensation Proxy SEC Filings — October 14, 2026

This digest covers 12 US SEC filings, all dated October 14, 2026, and centers on proxy statements (DEFM14A, DEF 14A) rather than executive pay disclosures. The stream focus is Executive Compensation Insights, and most filings present governance mechanics, shareholder votes, and merger or extension votes without compensation tables, so the enriched period-over-period, insider, and capital allocation fields are largely absent from the excerpts provided. The dominant theme is corporate restructuring and shareholder approval events: two large-cap transactions (Transocean/Valaris and Bowhead/American Family) and two SPAC deadline extensions (FACT II, Mountain Crest V) require holder votes in November 2026. Quantitative highlights include Atlassian's fiscal 2026 revenue up 26% y/y to $6.6 billion with Cloud revenue at $4.4 billion, Entera Bio's roughly $275 million private placement, and Valaris pro forma contract drilling revenue of $3,052 million for the six months to June 30, 2026. Governance themes include reverse split and dilution authority at Amesite, equity plan share increases at Entera Bio and Wave Life Sciences, and presiding-director and independence determinations at the Transcontinental/American Realty pair. Most filings are scheduled for November 10 to December 10, 2026 votes, so the near-term calendar is dense.

12 high priority 12 total filings
· daily

US Executive Officer Management Changes SEC — October 14, 2026

Across the 23 filings in the USA Executive & Director Changes stream (17 new, 6 contextual), the dominant theme is governance renewal: board refreshes with audit/finance expertise (Lisata, Compass, XTI, Jackson Financial, Enliven, Andersen Group), CEO and CFO successions (Verastem, PC Connection, Comtech, Mattel), and a cluster of C-suite departures at small and mid-cap names. The only filing with quantified period-over-period performance is State Street, which reported Q3 2026 diluted EPS of $3.69 (+33% YoY) and revenue of $4.0B (+13% YoY, -1% QoQ), but with mixed underlying detail: Other fee revenue fell 29% YoY and QoQ, FX trading services fell 14% QoQ, and CET1 declined 0.3 points YoY to 11.0%. Insider and compensation signals are noteworthy: Yext's 11M-share performance-based CEO option with 14 escalating price hurdles ($21 to $88.08) signals a long-dated conviction bet, while Alector's option repricing and Mattel's enhanced CEO change-in-control protections reflect retention-driven compensation design. The most material distress signals sit in Bubblr Inc., which is operating under a court-appointed receiver, with its CRO and a director resigning in early October. Several enriched financial fields (period comparisons, guidance, valuations) are empty for most filings, so the analytical edge here is primarily qualitative governance and timing.

23 high priority 23 total filings
· daily

US Corporate Board Director Changes SEC Filings — October 14, 2026

Across the 23 filings for the USA Board Room Changes stream (all dated 2026-10-14 window), the dominant theme is leadership reshuffling rather than financial performance: at least 10 filings involve CEO, CFO, CMO, CTO, CRO, CCO or General Counsel changes, director appointments, or board expansions. Only one filing (State Street) carries substantive period-over-period financials, and it is mixed: diluted EPS up 33% YoY to $3.69 and revenue up 13% YoY, but Other fee revenue fell 29% YoY and QoQ, FX trading services fell 14% QoQ, and CET1 slipped 0.3 pp YoY to 11.0%. Most other filings report no quantitative performance data, so the signal in this stream comes from governance quality, succession planning and transition risk. The most material governance developments are Verastem's planned CEO succession (Bailey replacing Paterson effective January 1, 2027), Comtech's CFO and CLO transitions tied to the Gilat sale of its Satellite & Space segment, and the court-appointed receivership at Bubblr where the Receiver is exercising board powers and officers are resigning. Director appointments skew toward experienced audit, CFO and life-science operators (Farrow at Lisata, Templin at Jackson, Ball at Enliven, Hsiao at Compass), which is a constructive governance pattern. Compensation design is also a recurring theme, with Yext's 11M-share performance option, Mattel's CEO severance raised to 2.99x with a 280G gross-up, and Alector's underwater option repricing. Overall, the stream reads as a mix of planned succession and governance strengthening against a small cluster of distressed or abrupt departures.

23 high priority 23 total filings
· daily

US Executive Compensation Proxy SEC Filings — October 13, 2026

This stream covers 20 DEF 14A proxy filings dated around October 13, 2026, and the enriched data is largely absent: nearly all filings report no period-over-period financial results, no insider transaction values, and no forward guidance. The governance content is the substance here, and it clusters into three recurring themes: Nasdaq listing and dilution remediation (Upexi, GT Biopharma, Healthcare Triangle, Health In Tech, Adagio Medical), reverse splits and authorized-share expansions, and concentrated voting control (Galectin, Health In Tech dual-class, Marathon Bancorp's 10% voting cutoff). Upexi is the single most material filing, with Nasdaq Staff having found two convertible note issuances in violation of Rule 5635(a) and up to ~42 million shares potentially issuable against a company whose listing is at stake. Several filings are routine director elections and auditor ratifications with no investment signal. Mutual-fund and closed-end fund proxies (Principal Funds, Principal ETFs, RMB Investors Trust, Japan Smaller Cap, SRH Total Return) concern fund governance rather than executive pay, and are treated as out of scope for this compensation-focused stream. Overall, the batch points to dilution pressure among micro-cap, Nasdaq-listed issuers, and should be read as a governance-risk digest rather than an executive-compensation one.

20 high priority 20 total filings
· daily

US Executive Officer Management Changes SEC — October 13, 2026

This Oct 13, 2026 digest covers 27 executive and director change filings, the bulk of them 8-Ks with no quantitative financial results attached, so the enriched period-over-period, insider-activity, and capital-allocation fields are largely empty across the stream. The dominant pattern is CFO and principal accounting officer turnover (Duos, Mueller Water, SAIC, Dauch/American Axle, Genworth, Lazard, Peloton, Crescent Private Credit, Expand Energy), with several finance-function reshuffles happening in the same October window. Governance stress is concentrated in small caps, most notably Nuvve's simultaneous exit of its Audit and Compensation Committee chairs, while larger names show orderly succession (Harmony, CSX, Danaher, Merck). The single most material item is Bausch + Lomb's abrupt CEO exit with Chairman Appio stepping in as interim CEO, coupled with a pre-announced guidance raise based on preliminary Q3 results. Most other filings explicitly disclaim disagreement with management, so the market read-through is mainly about bandwidth and execution timing rather than hidden accounting issues.

27 high priority 27 total filings
· daily

US Corporate Board Director Changes SEC Filings — October 13, 2026

This digest covers 27 SEC 8-K filings dated 2026-10-13 under the USA Board Room Changes stream (Officer Change, Director Change, Board Change). Nearly all filings are governance events rather than financial disclosures: the filings carry no period-over-period revenue, margin, or ratio data, so trend analysis is limited to the few that include guidance or capital-related items. The dominant pattern is a cluster of CFO, Chief Accounting Officer, and Principal Accounting Officer transitions (Mueller Water, SAIC, Dauch/American Axle, Genworth, Lazard, Peloton, Crescent Private Credit, Expand Energy, Duos), several of which are interim or retroactive arrangements and warrant closer governance review. The most material developments are Bausch + Lomb's abrupt CEO exit with an interim CEO who is also Bausch Health's CEO, alongside a guidance raise, and Nuvve's simultaneous resignation of its Audit and Compensation Committee chairs, which is the most negative governance signal in the set. Shareholder dissent was visible at MillerKnoll, where roughly 14.5% of votes cast on its incentive plan were against, versus under 3% on other proposals. Forward-looking items are sparse, with Harmony Biosciences the only clearly reaffirmed guidance (WAKIX net revenue $1.0B to $1.04B for 2026) and Bausch + Lomb expecting an EBITDA guidance raise with results on October 28.

27 high priority 27 total filings
· daily

US Executive Compensation Proxy SEC Filings — October 09, 2026

This digest covers 22 DEF 14A and DEFM14A filings for the 'Executive Compensation Insights' stream, centered on annual proxy statements, governance, and shareholder proposals. The filings are dominated by routine governance mechanics (director elections, auditor ratification, say-on-pay votes), with very few supplied with quantitative period-over-period financial data. The most substantive financial disclosures come from Coherent Corp. (record FY2026 revenue of $7.12B, up 22.5% YoY, GAAP gross margin up 233 bps to 37.5%), Sezzle (2025 net income $133.1M, up 70% YoY), and Performance Food Group (qualitative growth claims with no specific figures). The highest-materiality situations are corporate-action votes rather than compensation items: XWELL's airport-business sale with an unquantified arbitration exposure, and Newbury Street II's SPAC extension where post-redemption trust balances may fall far below the ~$186.9M held. Shareholder-dilution and capital-structure proposals (Envirotech's reverse split and preferred conversion, International Battery Metals' up-to-1-for-50 consolidation, Solidion's 975,000-share plan increase) cluster as a theme. Executive compensation disclosure is largely absent from the excerpts, which limits direct pay analysis and insider-activity signals. Overall, the stream's information content is thin, so the most actionable items are the time-sensitive votes and redemption deadlines.

22 high priority 22 total filings
· daily

US Executive Officer Management Changes SEC — October 09, 2026

The 33 filings in this stream are almost entirely Item 5.02 officer and director changes dated October 9, 2026, with no quantitative period-over-period financial data disclosed in any filing. Themes are clustered around CFO and finance-leadership turnover (Quantum, Standard Motor Products, Phoenix Education Partners, NextBoat, Bark's principal accounting officer), commercial and revenue leadership exits (Jazz, HealthEquity, Mitek, Veea, Myriad, Vogenx's conversion to CCO), and a wave of independent director appointments with strong operating or audit backgrounds (Cisco, Enerpac, Gen Digital, TOP Financial, Goldenwell). The most market-relevant developments are governance stress at Sidus Space (two director resignations citing governance disagreements, with the company disputing the characterizations), Quantum's CFO termination paired with a guidance-meeting expectation during an early close, and Quince/IRulya's CEO and COO turnover coinciding with a ticker change and pre-revenue pipeline readouts. Most other filings are neutral routine transitions, and the stream's most important near-term events are scheduled earnings and corporate actions (MSG spin-off record date October 20, Standard Motor Products and Avient Q3 reports, Quince's conversion and renaming on October 9 and 12).

33 high priority 33 total filings
· daily

US Corporate Board Director Changes SEC Filings — October 09, 2026

This board-room digest covers 33 SEC 8-K filings dated around October 9, 2026, all centred on officer and director changes rather than operating results. Nearly every filing is sentiment-neutral and explicitly disclaims any disagreement with management, which is the dominant pattern in the sample. The more consequential developments cluster around finance leadership: CFO exits or interim CFO appointments at Quantum, Phoenix Education Partners, Standard Motor Products, and Off the Hook/NextBoat, plus a PAO departure at BARK. Governance stress is most visible at Sidus Space, where two directors resigned citing governance and oversight disagreements, and at Quantum, where a CFO was terminated alongside an upbeat guidance statement. No filing in this set reports period-over-period financial figures, insider transactions, or capital allocation changes, so quantitative trend analysis is not possible from the enriched fields provided; the signals below rely on qualitative and governance data.

33 high priority 33 total filings
· daily

US Executive Compensation Proxy SEC Filings — October 08, 2026

This digest covers nine DEF 14A and DEFM14A filings dated around October 8, 2026, under a stream focused on executive compensation, governance, and shareholder proposals. The filings are dominated by annual meeting notices with proxy proposals (director elections, auditor ratification, say-on-pay, and equity plan changes), so most period-over-period financial comparisons are unavailable in the supplied excerpts. The clearest quantitative compensation trend comes from Leatt Corp, where CEO compensation actually paid rose from $231,762 in 2024 to $623,512 in 2025 (+169%), and average non-PEO NEO pay rose from $433,799 to $746,443 (+72%). AngioDynamics reported FY2026 GAAP revenue growth of 9.5%, with Med Tech up 18.4% and Med Device up only 2.6%, while its equity plan amendment seeks more shares. The most material development is the proposed merger of Cherry Hill Mortgage into TPG Mortgage Investment Trust, though the excerpt lacks deal terms. Governance themes include widespread use of equity plan share increases (Leatt, AngioDynamics, Palomino), reverse-split and blocker-driven ownership opacity (Jaguar Health), and interested-trustee structures (Robinhood Ventures Fund I). Several filings (Siebert, BGC) provided little legible content beyond headers and XBRL tags, which limits assessment.

9 high priority 9 total filings
· daily

US Executive Officer Management Changes SEC — October 08, 2026

This batch of 23 Officer and Director change filings (all dated October 8, 2026 window) is dominated by governance housekeeping, planned succession, and a handful of distressed or governance-stressed situations. Of the 23 filings, roughly 9 carry explicit succession or appointment content with forward-dated effective dates (General Dynamics, MFA Financial, Byline Bancorp, Henry Schein, OGE Energy, Vontier, Gartner, Kirby, Avalon GloboCare), while the rest are routine director resignations or retirements with no-disagreement language. No period-over-period financial metrics were disclosed in any filing, so trend analysis must rely on qualitative signals rather than YoY or QoQ figures. The most market-relevant items are the Lifeward CFO reversal (negative, interim leadership with no permanent CFO), the KonaTel sole-director board (governance concern), and the Avalon GloboCare interim CEO vacancy tied to a drone-defense acquisition pivot. On the positive side, eXp World/AGNT's CEO succession from a founder to an operator with a recent acquisition track record and RB Global's guidance reaffirmation to the high end stand out. Overall the stream signals a cluster of CFO and CLO turnover, which is worth monitoring for execution risk during reorganizations.

23 high priority 23 total filings
· daily

US Corporate Board Director Changes SEC Filings — October 08, 2026

This board-room digest covers 23 SEC 8-K filings dated around October 8, 2026, of which 22 fall within the Officer Change, Director Change, and Board Change scope; one filing (Byline-adjacent scope is retained, but Montrose/Onterris is retained as a director change) — in practice all 23 are governance events, so none are excluded. The dominant theme is leadership succession and planned transitions: General Dynamics' CEO handover (Danny Deep to CEO effective January 1, 2027, with Phebe Novakovic moving to executive chairman after serving since 2013), MFA Financial's CEO succession (Bryan Wulfsohn to CEO July 1, 2027), OGE Energy's COO elevation, and Byline Bancorp's commercial-banking reshuffle. A second cluster is CFO and legal-officer churn: Henry Schein is replacing its CFO after 18 years with incoming CFO Emmanuel Caprais, Gartner's Chief Legal Officer departs October 16, and Lifeward's CFO appointment collapsed before start. Several smaller-cap names show governance stress, most notably KonaTel (board cut to a single director who is also CEO and Chairman) and Avalon GloboCare (interim CEO resigned to pursue a drone-defense acquisition). Period-over-period financial metrics were not disclosed in most of these governance filings, so the analysis relies on qualitative and event-driven signals rather than YoY or QoQ trend data. Market implication: planned, internally driven successions (GD, MFA, OGE, RB Global) are generally low-risk, while unplanned departures at micro-caps and unexplained interim roles warrant closer scrutiny.

23 high priority 23 total filings
· daily

US Executive Compensation Proxy SEC Filings — October 07, 2026

The seven proxy filings reveal a polarized landscape in executive compensation and governance. Flexible Solutions and CISO Global show contrasting pay-performance alignment: Flexible cut CEO pay 30% despite TSR improvement but net income collapsed 74%, while CISO awarded 311% pay increases to executives who subsequently resigned. M&A activity dominates high-materiality filings: Centerspace's fixed-exchange merger with IRT and Charlton Aria's SPAC combination with KQC Quantum both carry significant execution and valuation risks. Onconetix continues its struggle with Nasdaq compliance, seeking a third reverse split in two years amid heavy dilution from PIPE and equity line transactions. In contrast, Clorox and SLR Investment present routine governance updates with strong insider ownership and enhanced risk oversight, offering stability. Overall, the stream highlights a divergence between companies using equity to retain talent versus those facing shareholder dilution and leadership churn.

7 high priority 7 total filings
· daily

US Executive Officer Management Changes SEC — October 07, 2026

The October 7, 2026 executive and director change filings reveal a wave of leadership transitions across US-listed companies, with notable activity in the technology and industrial sectors. Key themes include a significant number of CFO changes (BiomX, FuelCell Energy, Nukkleus, Advasa, Alkami, Matternet) and board refreshments (Crane NXT, WillScot, BCB Bancorp, TE Connectivity, Nutanix). Several transitions are tied to major corporate actions, such as Corteva's spin-off of Vylor Inc. and Boston Scientific's segment reorganization, which signal strategic pivots. Compensation packages for new executives are substantial, indicating competitive talent markets, particularly in tech and healthcare. While most transitions are orderly, BiomX's going concern qualification and CEO compensation structure, along with Matternet's CFO departure and option extension, warrant close monitoring. Overall, the period reflects a healthy churn in leadership, with a mix of routine governance updates and strategic appointments that could impact company performance and investor sentiment.

17 high priority 17 total filings